RATIONALE: We previously reported highly increased levels of specific IgE antibodies (sIgE) to vaccine component in children with influenza vaccine-induced anaphylaxis (J Allergy Clin Immunol 2016). We investigated whether inactivated influenza vaccine induces vaccine-specific IgE antibody in general population and sought risk factors of sensitization. METHODS: Subjects were children/adolescent (0 to 18 years old) who participated in a clinical trial to compare immunogenicity of trivalent and quadrivalent inactivated influenza vaccines. Serum samples were obtained before and 3-4 weeks after 1 st and 2 nd dose of vaccination. The subjects >13 years old received only 1 dose. Influenza vaccine-sIgE (IV-sIgE) was measured with ImmunoCAPÒ assay system. ImmunoCAP titer>0.1 U/ml was regarded as positive. RESULTS: A total of 393 subjects were enrolled in the study, consisting of 4 age-groups; 0-2-year-old (N595), 3-5-year-old (n5101), 6-12-year-old (n5100) and 13-18-year-old (n597). No systemic adverse events occurred. Local reactions were observed in 30% of the subjects. Prevalence of sensitization to the vaccine before vaccination was 30%, 72%, 62% and 50 % in 0-2, 3-5, 6-12, and 13-18-year-old groups, respectively. IV-sIgE titers were significantly elevated after 1 st dose in 0-2 and 3-5-year-old groups, no further elevation after 2 nd dose. The titers in age groups of 6 years and older did not change after vaccination. Elevation of sIgE was associated with the local reactions. Multi-variate logistic analysis revealed that history of asthma and young age were significant risk factors for sensitization. CONCLUSIONS: Influenza vaccine induces IgE sensitization in young children, which may predispose vaccine-induced anaphylaxis. 
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Gender differences in dendritic cell population in nasal and oral cavity between allergic and non-allergic subjects.
Joshua K. Baguley, MS, Shandra V. Bellinger, MS, Hayat H. Srour, MS, Ariel J. Stateman, MS, and Felix E. Rivera-Mariani, PhD; College of Biomedical Sciences, Larkin University, Miami, FL. RATIONALE: It is well documented that male and female immune systems differ physiologically, leading to different responses against invading pathogens. It stands to reason that the different responses are reflected in the populations of immune cells. As dendritic cells (DC) are integral participants of both innate and adaptive immune responses, it is possible that males and females vary in the concentration of tissue-resident DCs, such as in the nasal and oral mucosa. METHODS: A public-available dataset (https://doi.org/10.5281/zenodo. 50228) with DC counts obtained from biopsies of the epithelium and lamina propria of both the nasal and oral mucosa was analyzed using a two sample t-test. DC counts from biopsies of male and female subjects, with and without upper respiratory allergy, were compared to determine if there was significant differences by gender. RESULTS: When considering the biopsies from both nasal epithelium (epi) and nasal lamina propria (LP), females (9.418 LC/mmepi and 6.431 LC/mmLP) had a significantly higher DC count than males (5.464 LC/ mmepi and 3.629 LC/mmLP). Further analysis determined that there was no significant difference in the concentrations of DCs in biopsies obtained from the oral mucosa, and when stratifying by presence or absence of upper respiratory allergies. CONCLUSIONS: Variations in DC population concentration potentially contribute to the physiological differences in immune response between the two genders. Further investigation into immunological cell populations of various tissues could improve the understanding of gender differences in regards to the immune system.
